$EBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Emergent BioSolutions Inc.. Get notifications about new insider transactions in Emergent BioSolutions Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 21 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2020 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 56.93 | 6,572 | 374,132 | 39,761 | 46.3 K to 39.8 K (-14.18 %) |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,794 | 0 | 37,980 | |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,429 | 0 | 47,774 | |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 56.97 | 9,837 | 560,414 | 1,469,046 | 1.5 M to 1.5 M (-0.67 %) |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 58.42 | 3,854 | 225,151 | 1,478,883 | 1.5 M to 1.5 M (-0.26 %) |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,794 | 0 | 1,482,737 | 1.5 M to 1.5 M (+0.66 %) |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 58.70 | 13,619 | 799,435 | 1,472,943 | 1.5 M to 1.5 M (-0.92 %) |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 59.91 | 2,530 | 151,572 | 1,486,562 | 1.5 M to 1.5 M (-0.17 %) |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,429 | 0 | 1,489,092 | 1.5 M to 1.5 M (+0.43 %) |
| Feb 28 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 59.91 | 2,365 | 141,687 | 1,482,663 | 1.5 M to 1.5 M (-0.16 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Option Exercise | A | 61.44 | 22,784 | 1,399,849 | 43,105 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Option Exercise | A | 61.44 | 22,784 | 1,399,849 | 43,105 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 59.91 | 582 | 34,868 | 40,799 | 41.4 K to 40.8 K (-1.41 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 59.91 | 582 | 34,868 | 40,799 | 41.4 K to 40.8 K (-1.41 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 59.91 | 508 | 30,434 | 41,381 | 41.9 K to 41.4 K (-1.21 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 59.91 | 508 | 30,434 | 41,381 | 41.9 K to 41.4 K (-1.21 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,697 | 0 | 41,889 | 36.2 K to 41.9 K (+15.74 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,697 | 0 | 41,889 | 36.2 K to 41.9 K (+15.74 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,697 | 0 | 36,192 | 30.5 K to 36.2 K (+18.68 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,697 | 0 | 36,192 | 30.5 K to 36.2 K (+18.68 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Option Exercise | A | 61.44 | 14,648 | 899,973 | 43,225 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Option Exercise | A | 61.44 | 14,648 | 899,973 | 43,225 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 58.42 | 387 | 22,609 | 28,246 | 28.6 K to 28.2 K (-1.35 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 58.42 | 387 | 22,609 | 28,246 | 28.6 K to 28.2 K (-1.35 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 59.91 | 381 | 22,826 | 28,633 | 29 K to 28.6 K (-1.31 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 59.91 | 381 | 22,826 | 28,633 | 29 K to 28.6 K (-1.31 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 59.91 | 498 | 29,835 | 29,014 | 29.5 K to 29 K (-1.69 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 59.91 | 498 | 29,835 | 29,014 | 29.5 K to 29 K (-1.69 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 3,662 | 0 | 29,512 | 25.9 K to 29.5 K (+14.17 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 3,662 | 0 | 29,512 | 25.9 K to 29.5 K (+14.17 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 3,662 | 0 | 25,850 | 22.2 K to 25.9 K (+16.50 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 3,662 | 0 | 25,850 | 22.2 K to 25.9 K (+16.50 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | A | 61.44 | 22,784 | 1,399,849 | 43,105 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | A | 61.44 | 22,784 | 1,399,849 | 43,105 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 58.42 | 409 | 23,894 | 42,228 | 42.6 K to 42.2 K (-0.96 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 58.42 | 409 | 23,894 | 42,228 | 42.6 K to 42.2 K (-0.96 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 59.91 | 484 | 28,996 | 42,637 | 43.1 K to 42.6 K (-1.12 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 59.91 | 484 | 28,996 | 42,637 | 43.1 K to 42.6 K (-1.12 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 59.91 | 513 | 30,734 | 43,121 | 43.6 K to 43.1 K (-1.18 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 59.91 | 513 | 30,734 | 43,121 | 43.6 K to 43.1 K (-1.18 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,697 | 0 | 43,634 | 37.9 K to 43.6 K (+15.02 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,697 | 0 | 43,634 | 37.9 K to 43.6 K (+15.02 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,697 | 0 | 37,937 | 32.2 K to 37.9 K (+17.67 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,697 | 0 | 37,937 | 32.2 K to 37.9 K (+17.67 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,010 | 0 | 54,203 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,010 | 0 | 54,203 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 19,532 | 0 | 60,213 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 19,532 | 0 | 60,213 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 61.44 | 39,061 | 2,399,908 | 39,061 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 61.44 | 39,061 | 2,399,908 | 39,061 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,010 | 0 | 1,485,028 | 1.5 M to 1.5 M (+0.41 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,010 | 0 | 1,485,028 | 1.5 M to 1.5 M (+0.41 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Option Exercise | A | 61.44 | 14,648 | 899,973 | 37,668 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Option Exercise | A | 61.44 | 14,648 | 899,973 | 37,668 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Payment of Exercise | F | 58.42 | 608 | 35,519 | 19,661 | 20.3 K to 19.7 K (-3.00 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Payment of Exercise | F | 58.42 | 608 | 35,519 | 19,661 | 20.3 K to 19.7 K (-3.00 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Payment of Exercise | F | 59.91 | 277 | 16,595 | 20,269 | 20.5 K to 20.3 K (-1.35 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Payment of Exercise | F | 59.91 | 277 | 16,595 | 20,269 | 20.5 K to 20.3 K (-1.35 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Payment of Exercise | F | 59.91 | 382 | 22,886 | 20,546 | 20.9 K to 20.5 K (-1.83 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Payment of Exercise | F | 59.91 | 382 | 22,886 | 20,546 | 20.9 K to 20.5 K (-1.83 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Grant | A | 0.00 | 3,662 | 0 | 20,928 | 17.3 K to 20.9 K (+21.21 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Grant | A | 0.00 | 3,662 | 0 | 20,928 | 17.3 K to 20.9 K (+21.21 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Grant | A | 0.00 | 3,662 | 0 | 17,266 | 13.6 K to 17.3 K (+26.92 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Grant | A | 0.00 | 3,662 | 0 | 17,266 | 13.6 K to 17.3 K (+26.92 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 61.44 | 24,414 | 1,499,996 | 44,735 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 61.44 | 24,414 | 1,499,996 | 44,735 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 59.91 | 610 | 36,545 | 32,534 | 33.1 K to 32.5 K (-1.84 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 59.91 | 610 | 36,545 | 32,534 | 33.1 K to 32.5 K (-1.84 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 6,104 | 0 | 33,144 | 27 K to 33.1 K (+22.57 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 6,104 | 0 | 33,144 | 27 K to 33.1 K (+22.57 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 6,103 | 0 | 27,040 | 20.9 K to 27 K (+29.15 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 6,103 | 0 | 27,040 | 20.9 K to 27 K (+29.15 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | A | 61.44 | 66,731 | 4,099,953 | 113,928 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | A | 61.44 | 66,731 | 4,099,953 | 113,928 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 59.91 | 1,126 | 67,459 | 142,298 | 143.4 K to 142.3 K (-0.79 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 59.91 | 1,126 | 67,459 | 142,298 | 143.4 K to 142.3 K (-0.79 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 58.42 | 778 | 45,451 | 143,424 | 144.2 K to 143.4 K (-0.54 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 58.42 | 778 | 45,451 | 143,424 | 144.2 K to 143.4 K (-0.54 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 59.91 | 558 | 33,430 | 144,202 | 144.8 K to 144.2 K (-0.39 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 59.91 | 558 | 33,430 | 144,202 | 144.8 K to 144.2 K (-0.39 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 16,683 | 0 | 144,760 | 128.1 K to 144.8 K (+13.03 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 16,683 | 0 | 144,760 | 128.1 K to 144.8 K (+13.03 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 16,683 | 0 | 128,077 | 111.4 K to 128.1 K (+14.98 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 16,683 | 0 | 128,077 | 111.4 K to 128.1 K (+14.98 %) |
| Feb 25 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 18.64 | 5,152 | 96,033 | 7,893 | |
| Feb 25 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 65.00 | 5,152 | 334,880 | 16,395 | 21.5 K to 16.4 K (-23.91 %) |
| Feb 25 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 18.64 | 5,152 | 96,033 | 31,851 | 26.7 K to 31.9 K (+19.30 %) |
| Feb 25 2020 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 70.00 | 6,572 | 460,040 | 11,752 | 18.3 K to 11.8 K (-35.87 %) |
| Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 18,567 | 475,687 | 0 | |
| Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 4,751 | 121,721 | 18,567 | |
| Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 64.90 | 18,567 | 1,204,998 | 1,479,018 | 1.5 M to 1.5 M (-1.24 %) |
| Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 18,567 | 475,687 | 1,497,585 | 1.5 M to 1.5 M (+1.26 %) |
| Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 64.90 | 4,751 | 308,340 | 1,479,018 | 1.5 M to 1.5 M (-0.32 %) |
| Feb 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 4,751 | 121,721 | 1,483,769 | 1.5 M to 1.5 M (+0.32 %) |
| Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 15,614 | 400,031 | 23,318 | |
| Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 4,386 | 112,369 | 38,932 | |
| Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 63.90 | 15,614 | 997,735 | 1,479,018 | 1.5 M to 1.5 M (-1.04 %) |
| Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 15,614 | 400,031 | 1,494,632 | 1.5 M to 1.5 M (+1.06 %) |
| Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 63.90 | 4,386 | 280,265 | 1,479,018 | 1.5 M to 1.5 M (-0.30 %) |
| Feb 19 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 4,386 | 112,369 | 1,483,404 | 1.5 M to 1.5 M (+0.30 %) |
| Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 13,720 | 351,506 | 43,318 | |
| Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 25.62 | 6,280 | 160,894 | 57,038 | |
| Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.90 | 13,720 | 862,988 | 1,479,018 | 1.5 M to 1.5 M (-0.92 %) |
| Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 13,720 | 351,506 | 1,492,738 | 1.5 M to 1.5 M (+0.93 %) |
| Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.90 | 6,280 | 395,012 | 1,479,018 | 1.5 M to 1.5 M (-0.42 %) |
| Feb 13 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 25.62 | 6,280 | 160,894 | 1,485,298 | 1.5 M to 1.5 M (+0.42 %) |
| Feb 07 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Executive Chairman | Sell | S | 61.90 | 11,684 | 723,240 | 1,419,018 | 1.4 M to 1.4 M (-0.82 %) |
| Feb 07 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Executive Chairman | Sell | S | 60.66 | 48,316 | 2,930,849 | 1,430,702 | 1.5 M to 1.4 M (-3.27 %) |
| Jan 17 2020 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 55.00 | 3,435 | 188,925 | 36,273 | 39.7 K to 36.3 K (-8.65 %) |
| Dec 13 2019 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 53.46 | 8,375 | 447,728 | 46,333 | 54.7 K to 46.3 K (-15.31 %) |
| Nov 19 2019 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 54.31 | 1,000 | 54,314 | 17,412 | 18.4 K to 17.4 K (-5.43 %) |
| Nov 12 2019 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 54.15 | 3,082 | 166,884 | 18,412 | 21.5 K to 18.4 K (-14.34 %) |
| Nov 12 2019 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 54.15 | 3,082 | 166,884 | 18,412 | 21.5 K to 18.4 K (-14.34 %) |
| Nov 12 2019 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 18.64 | 5,153 | 96,052 | 5,152 | |
| Nov 12 2019 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 60.00 | 5,153 | 309,180 | 26,699 | 31.9 K to 26.7 K (-16.18 %) |
| Nov 12 2019 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 18.64 | 5,153 | 96,052 | 31,852 | 26.7 K to 31.9 K (+19.30 %) |
| Sep 10 2019 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 56.12 | 1,509 | 84,692 | 21,494 | 23 K to 21.5 K (-6.56 %) |
| Aug 09 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 44.47 | 1,287 | 57,233 | 30,495 | 31.8 K to 30.5 K (-4.05 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 43.39 | 1,376 | 59,702 | 23,003 | 24.4 K to 23 K (-5.64 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Grant | A | 0.00 | 5,736 | 0 | 24,379 | 18.6 K to 24.4 K (+30.77 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Grant | A | 0.00 | 5,736 | 0 | 18,324 | 12.6 K to 18.3 K (+45.57 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 5,736 | 0 | 60,466 | 54.7 K to 60.5 K (+10.48 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 5,736 | 0 | 26,699 | 21 K to 26.7 K (+27.36 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Grant | A | 0.00 | 5,736 | 0 | 39,708 | 34 K to 39.7 K (+16.88 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Grant | A | 0.00 | 5,736 | 0 | 54,708 | 49 K to 54.7 K (+11.71 %) |
| May 28 2019 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Grant | A | 0.00 | 5,736 | 0 | 31,950 | 26.2 K to 32 K (+21.88 %) |
| May 10 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 47.49 | 759 | 36,045 | 20,937 | 21.7 K to 20.9 K (-3.50 %) |
| May 10 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 47.49 | 237 | 11,255 | 22,188 | 22.4 K to 22.2 K (-1.06 %) |
| May 10 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 47.49 | 95 | 4,512 | 111,394 | 111.5 K to 111.4 K (-0.09 %) |
| May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 13.37 | 7,893 | 105,529 | 0 | |
| May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 49.41 | 2,135 | 105,490 | 54,730 | 56.9 K to 54.7 K (-3.75 %) |
| May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 13.37 | 7,893 | 105,529 | 56,865 | 49 K to 56.9 K (+16.12 %) |
| Mar 21 2019 | EBS | Emergent BioSoluti ... | Mulligan Seamus | Director | Grant | A | 0.00 | 7,569 | 0 | 56,141 | 48.6 K to 56.1 K (+15.58 %) |
| Mar 13 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 56.93 | 2,430 | 138,340 | 32,240 | 34.7 K to 32.2 K (-7.01 %) |
| Mar 04 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 58.20 | 2,024 | 117,797 | 34,670 | 36.7 K to 34.7 K (-5.52 %) |
| Mar 04 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 57.92 | 1,019 | 59,022 | 36,694 | 37.7 K to 36.7 K (-2.70 %) |
| Mar 04 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 58.11 | 14,565 | 846,328 | 142,617 | 157.2 K to 142.6 K (-9.27 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | A | 61.01 | 20,321 | 1,239,784 | 20,321 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 58.71 | 812 | 47,673 | 37,713 | 38.5 K to 37.7 K (-2.11 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 57.98 | 409 | 23,714 | 38,525 | 38.9 K to 38.5 K (-1.05 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,081 | 0 | 38,934 | 33.9 K to 38.9 K (+15.01 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,081 | 0 | 33,853 | 28.8 K to 33.9 K (+17.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 61.01 | 481 | 29,346 | 28,772 | 29.3 K to 28.8 K (-1.64 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Option Exercise | A | 61.01 | 47,197 | 2,879,489 | 47,197 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Payment of Exercise | F | 58.71 | 1,941 | 113,956 | 111,489 | 113.4 K to 111.5 K (-1.71 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Payment of Exercise | F | 57.98 | 779 | 45,166 | 113,430 | 114.2 K to 113.4 K (-0.68 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Grant | A | 0.00 | 11,801 | 0 | 114,209 | 102.4 K to 114.2 K (+11.52 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Grant | A | 0.00 | 11,801 | 0 | 102,408 | 90.6 K to 102.4 K (+13.02 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Payment of Exercise | F | 61.01 | 565 | 34,471 | 90,607 | 91.2 K to 90.6 K (-0.62 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Option Exercise | A | 61.01 | 20,321 | 1,239,784 | 20,321 |